Table 2

The mean presentation AT PWs and average MD values at presentation and final visits for clinic VFs with presentation AT PWs above and below the mean

PresentationFinal visits
Mean AT PW, %Average MD for VFs with presentation AT PWs below the mean, dBAverage MD for VFs with presentation AT PWs above the mean, dBP valueAverage MD for VFs with presentation AT PWs below the mean, dBAverage MD for VFs with presentation AT PWs above the mean, dBP value
Clinic-derived AT123 (19 to 27)−19.75
(–22.48 to –17.03)
−5.35
(−6.09 to –4.62)
<0.001−4.51
(−6.63 to –2.39)
−1.20
(−1.61 to –0.80)
<0.001
ONTT-derived AT118 (14 to 22)−19.09
(–21.95 to –16.23)
−4.77
(−5.41 to –4.13
<0.001−4.24
(−6.32 to –2.15)
−1.30
(−1.90 to –0.87)
<0.001
Clinic-derived AT313 (9 to 17)−9.72
(–11.82 to –7.63)
−27.21
(–29.11 to –25.29)
<0.001−1.79
(−2.86 to –0.71)
−7.73
(–10.05 to –5.41)
<0.001
ONTT-derived AT216 (12 to 20)−9.65
(–11.77 to –7.54)
−26.50
(–28.63 to –24.36)
<0.001−2.10
(−3.22 to –0.98)
−6.45
(−8.92 to –3.99)
<0.001
  • 95% CIs are shown in parentheses.

  • AT, archetype; MD, mean deviation; ONTT, Optic Neuritis Treatment Trial; PW, per cent weight; VF, visual field.